Archive for category: News

LRC-TriCEPS target identification on living cells – can it be replaced by AI?

Can AI replace LRC-TriCEPS for target discovery on living cells? See how Boltz-2.1 performed across four validated real-life projects.

Collaboration with aTyr Pharma Announces Research

Dualsystems Biotech is very excited to start a 3 year non-exclusive collaboration with aTyr Pharma to identify 10 novel therapeutic drug targets.
With our LRC-TriCEPS platform we can identify targets on living cells and have identified in the past many novel interactions.

Dualsystems announces collaboration to identify new targets of Covid-19

Dualsystems Biotech AG celebrates its 20th Anniversary

Comparison of different Ligang-receptor identification methodologies by Dualsystems

New Publication – Validation of extracellular ligand–receptor interactions by Flow-TriCEPS

Dualsystems Biotech wins the 3rd price at the Sino-Europe Innovation Week in Healthcare Technology

Staphylococcal Superantigens Use LAMA2 as a Coreceptor for GPCR signaling To Activate T Cells

HATRIC-based identification of receptors for orphan ligands (small molecules)

Scratching the surface: Technologies for targeting the cell surfaceome

DO YOU WANT TO TEST IT NOW?

Transport not incl. Your Information will never be shared with any third party.

To get pretest TriCEPS Material please contact us!

Identify the targets of your ligand on the living cells. Prior to the main experiment get free TriCEPS Material to test the functionality of your TriCEPS coupled ligand.

Extracellular proteins
Peptide ligands
Antibodies
Engineered affinity binders
Viruses

DO YOU WANT TO TALK TO US?

Your information will never be shared with any third party.

LRC-TriCEPS to identify targets on the surface of living cells.

Please provide your email address and we will contact you to arrange a call.

Small molecules
Extracellular proteins
Peptide ligands
Antibodies
Engineered affinity binders
Viruses